These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 34378851)
1. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA. Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851 [TBL] [Abstract][Full Text] [Related]
2. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma. Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955 [TBL] [Abstract][Full Text] [Related]
3. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321 [No Abstract] [Full Text] [Related]
4. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma. Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816 [TBL] [Abstract][Full Text] [Related]
5. A Novel Prognostic Signature of Immune-Related Long Noncoding RNA Pairs for Tumor-Infiltrating Immune Cells and Drug Susceptibility in Breast Cancer. Li S; Sun X; Li J; Zheng A; Cao Y; Guo Y; Jin F DNA Cell Biol; 2022 Feb; 41(2):103-115. PubMed ID: 34762509 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer. Meisel JL; Zhao J; Suo A; Zhang C; Wei Z; Taylor C; Aneja R; Krishnamurti U; Li Z; Nahta R; O'Regan R; Li X Clin Breast Cancer; 2020 Feb; 20(1):19-24. PubMed ID: 31806448 [TBL] [Abstract][Full Text] [Related]
8. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Hu X; Wu L; Liu B; Chen K Front Immunol; 2021; 12():651056. PubMed ID: 34122409 [TBL] [Abstract][Full Text] [Related]
9. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma. Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044 [TBL] [Abstract][Full Text] [Related]
10. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer. Xu M; Li Q; Zhang J; Xie H Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study. Li YC; Zhou Q; Song QK; Wang RB; Lyu S; Guan X; Zhao YJ; Wu JP J Immunol Res; 2020; 2020():3948928. PubMed ID: 32411795 [TBL] [Abstract][Full Text] [Related]
12. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
13. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
14. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer. Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363 [TBL] [Abstract][Full Text] [Related]
15. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC. Dai L; Pan D; Jin J; Lv W Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738 [TBL] [Abstract][Full Text] [Related]
16. Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer. Tan L; He X; Shen G Aging (Albany NY); 2020 Dec; 13(10):14499-14521. PubMed ID: 33378744 [TBL] [Abstract][Full Text] [Related]
17. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients. Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920 [TBL] [Abstract][Full Text] [Related]
18. Metaplastic breast cancer: an old histotype but a current therapeutic problem. Gadaleta-Caldarola G; Nenna R; Lanotte L; Doronzo A; Gadaleta-Caldarola A; Roma I; Lombardi L; Infusino S Future Oncol; 2021 Mar; 17(8):955-963. PubMed ID: 33538176 [TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer. Hua S; Xie Z; Wang W; Wan Z; Chen M; Zhao S; Jiang J Front Oncol; 2021; 11():704946. PubMed ID: 34322391 [TBL] [Abstract][Full Text] [Related]
20. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer. Wang X; Chen K; Wang Z; Xu Y; Dai L; Bai T; Chen B; Yang W; Chen W Front Cell Dev Biol; 2021; 9():750709. PubMed ID: 34660608 [No Abstract] [Full Text] [Related] [Next] [New Search]